SCHEMBL16726760

SCHEMBL16726760

Cc1ccc2c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc3n(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.38
▸ RXFP1 Q9HBX9 2/20 0.38
▸ AVPR1A P37288 1/20 0.37
▸ SIRT2 Q8IXJ6 1/20 0.37
▸ SIRT1 Q96EB6 1/20 0.37
▸ NPY5R Q15761 1/20 0.36
▸ ADORA3 P0DMS8 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NLRP3 Q96P20 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17051476 0.98 L3MBTL1 (0.41) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL17032755 0.98 L3MBTL1 (0.41) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL16726772 0.98 L3MBTL1 (0.41) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL16726771 0.95 ATM (0.43) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL16726768 0.95 ATM (0.43) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL14748570 0.94 ALDH1A1 (0.40) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL14748512 0.94 ALDH1A1 (0.40) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL16726731 0.94 L3MBTL1 (0.44) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL16726742 0.94 L3MBTL1 (0.44) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL17032781 0.93 KDM4E (0.38) PTGER4KDM4EATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131934-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-27 — — US disclosed
US-20150243903-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2015-08-27 — — US disclosed
US-20150159084-A1 NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MAT (KR) 2015-06-11 — — US disclosed
US-20150159084-A1 NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MAT (KR) 2015-06-11 — — US disclosed
US-20150137051-A1 NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MAT (KR) 2015-05-21 — — US disclosed
US-20150137051-A1 NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MAT (KR) 2015-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243903-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP PTGER4 836/4885KDM4E 4278/4885ATM 4635/4885
US-20230131934-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP PTGER4 836/4885KDM4E 4278/4885ATM 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback